← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 31, 2020Last known activity
Jan 31, 2023
Timeline
2010s
- Jun 1, 2016
Seelos Therapeutics— Founded
- Jan 1, 2019
Apricus Biosciences— Acquired
- Feb 19, 2019
Bioblast Pharma Ltd.— Acquired
Drugs by trial phase (6 distinct, 13 trials)
Phase 3 (0 own, 1 via acquisition)
Phase 2 (1 own, 2 via acquisition)
Phase 1 (0 own, 2 via acquisition)
Indications
Subsidiaries (2 direct, 4 total across the full acquisition tree)
Recent trials (5)
- NCT05597436Lead sponsorN/A—
- NCT05332678Lead sponsorPhase 2Jan 31, 2023
- NCT05490563Lead sponsorPhase 2/Phase 3Jun 3, 2022
- NCT05136885CollaboratorPhase 2/Phase 3Dec 31, 2021
- NCT04669665Lead sponsorPhase 2Dec 31, 2020
Details
- Founded
- New York, NY, US Jun 1, 2016
- Last known activity
- Jan 31, 2023